Organization · Venture Capital
Foresite Capital
Foresite Capital is a multi-stage healthcare and life sciences investment firm based in the San Francisco Bay Area. They utilize a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare.
Overview
What Foresite Capital does
What Foresite Capital is
Foresite Capital is a multi-stage healthcare and life sciences investment firm based in the San Francisco Bay Area. They utilize a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- February 28, 2026
Official channels
Find Foresite Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Foresite Capital as a funder
Investment thesis
Multi-stage healthcare and life sciences firm investing in companies leveraging biology and big data to transform healthcare
Focus narrative
50% early-stage, 50% late-stage. Therapeutics (oncology, autoimmune, neuroscience), life sciences infrastructure, precision medicine. Foresite Labs incubates early concepts.
Value beyond capital
Multidisciplinary team of scientists, engineers, analysts, clinicians. Deep healthcare business model expertise. Collaborative approach with portfolio companies.
Terms and economics
- Typical check
- $50,000,000–$120,000,000
- Sweet spot
- $83,000,000
Focus and fit
- Stages
- Series A · Series B · Series C · Series D · Growth Equity
- Sectors
- Biotech · Healthcare · Drug Discovery · Diagnostics · Digital Health · Genomics
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 206
- Investments in the last 12 months
- 9
- Last recorded investment
- February 3, 2026
- Recorded notable exits
- 10x Genomics, Relay Therapeutics, Editas Medicine, Juno Therapeutics, Vaxcyte, and Natera
Portfolio context
206 companies with 237 exits (80 IPOs, 65 acquisitions). Includes 10x Genomics, Relay Therapeutics, Natera, Editas Medicine, Color Genomics, Insitro.
Common questions
What to know about Foresite Capital
Upseed classifies Foresite Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
February 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.